ING Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-456,177
| Closed | -$6.97M | – | 763 |
|
|
2018
Q2 | $6.97M | Buy |
+456,177
| New | +$6.97M | 0.13% | 95 |
|
|
2017
Q2 | – | Sell |
-11,300
| Closed | -$388K | – | 826 |
|
|
2017
Q1 | $388K | Sell |
11,300
-19,665
| -64% | -$675K | 0.01% | 474 |
|
|
2016
Q4 | $891K | Sell |
30,965
-4,000
| -11% | -$115K | 0.02% | 333 |
|
|
2016
Q3 | $1.14M | Buy |
+34,965
| New | +$1.14M | 0.01% | 274 |
|
|
2013
Q4 | – | Sell |
-41,000
| Closed | -$1.13M | – | 687 |
|
|
2013
Q3 | $1.13M | Buy |
+41,000
| New | +$1.13M | 0.01% | 548 |
|